These Large Cannabis Companies May Need to Sell Stock

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015.

During the quarter, it repurchased C$7.1 million at a discount, and the company used the proceeds from its ATM to get more aggressive, disclosing that after the quarter it purchased another C$13.4 million of debt at a steep discount.

Given that the company is experiencing a decline in revenue as it continues to generate large operating losses, we think that Aurora is prudent to sell shares in the market above tangible book value, especially in light of the situation at HEXO Corp.

We recently discussed the challenges at Canopy Growth and its deteriorating financial position.

If analysts are correct in their outlook that Canopy Growth won’t reach positive adjusted EBITDA until three years from now, the ability to refinance the debt will be increasingly questioned.

This debt includes two convertible notes: $278 million due in 2023 and $260 million due in 2024 unless they are able to borrow more.

When we interviewed its CEO, Irwin Simon, last August, he expressed hope that the company would see its 2024 debt converted into stock, but its stock has declined from $14 to $6 since then.

While the stocks of all three companies are down substantially from where they have been historically, biting the bullet to strengthen the balance sheet may be necessary to restore investor confidence.

Learn how to differentiate between the stronger and weaker cannabis companies with a subscription to Alan Brochstein’s 420 Investor.

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter.

Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames.

…Read the full story